Mouth cancer
Role of Afatinib plus chemotherapy versus chemotherapy alone in treatment of locally advanced oral cancers
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyPhase 4: after approval
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Datta Meghe Institute of Higher Education and ResearchIndiaDirections ↗
Registry summary (technical)
A comparative efficacy and safety of Oral Afatinib Targeted therapy plus chemotherapy versus Chemotherapy alone in locally advanced squamous cell cancer of Head and neck region from Tertiary care hospital in central India: A Randomized controlled trial - NIL
Sponsor: Datta Meghe Institute of Higher Education and Research
CTRI/2025/03/082447 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 8 Dec 2025 · read by us 5 Nov 2026